Neuropsychopharmacology
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
A 14-Week, Randomized, Placebo-Controlled Cross-Over Study of Multilayer Release Methylphenidate in Adult ADHD With and Without Anxiety Disorder Comorbidity
2023
-
A Network Control Theory Approach to Relapse Prediction in Major Depressive Disorder: A Report From the CAN-BIND-1 Trial and Wellness Monitoring Study
2023
-
Intrinsic Network Disruptions in Major Depressive Disorder Revealed by Whole-Brain Functional Connectivity Multi-Voxel Pattern Analysis
2023
-
Pharma-Psychosocial Treatment for Individuals With Substance Use Disorders in a Canadian Forensic Program
2023
-
Polygenic Risk Score Analysis of Antidepressant Treatment Response: Results From the CAN-BIND-1 Cohort
2023
-
Applying Behavioral Economics to Screen Medications for Alcohol Use Disorder
2022
-
CADM2 is Implicated in Impulsive Personality Traits by Genome- and Phenome-Wide Association Studies in Humans, With Further Support From Studies of CADM2 Mutant Mice
2022
-
Clinical Psychopharmacology: Racial and Ethnic Issues
2022
-
Clinical Psychopharmacology: Racial and Ethnic Issues
2022
-
Correlates and Patterns of Cannabis Use in an ADHD Sample
2022
-
Correlates and Patterns of Cannabis Use in an ADHD Sample
2022
-
Obsessive Compulsive Disorder During the COVID-19 Pandemic
2021
-
Polygenic Contributions to Risk Taking as Measured by the Balloon Analogue Risk Task
2021
-
A Pilot Survey of Cannabis Use in Individuals With Obsessive Compulsive Disorder
2019
-
Exploring the Genetic Architecture of Mood Symptoms in Postpartum Depression and Postpartum Psychosis Using Polygenic Risk Scores
2019
-
Acute Stress Effects on Decision-Making in Gambling Disorder
2018
-
Anxiety and Depressive Symptom Prevalence in a Canadian Medical Cannabis Use Cohort
2018
-
Elucidating the Effect of a Brief Motivational Drinking Intervention Using Neuroimaging: A Preliminary Study
2018
-
Escitalopram Response is Associated With Pre-Treatment Neuraland Clinical Correlates of Anhedonia
2018
-
Genetic Variants of OCD Phenotypes and Comorbid Conditions
2018
-
Impact of CYP2C19 and CYP2D6 Genotypes on Clinical Outcomes and Side Effects in Patients Receiving Escitalopram and Aripiprazole for Major Depression: Results From the Can-Bind Cohort
2018
-
Machine Learning Multivariate Pattern Analysis Predicts Classification of Posttraumatic Stress Disorder and its Dissociative Subtype
2018
-
Acute and Prolonged Antidepressant Effects of Ketamine in Treatment-Resistant Depression
2017
-
Findings From Baseline Neuroimaging Data in a Double-Blind Randomized Controlled Trial of rTMS for Executive Function Deficits for ASD
2017
-
Genome-Wide Association Study of Impulsivity: Relevance to Substance Use Disorders
2017
-
Lisdexamfetamine Dimesylate in the Treatment of Adult ADHD With Anxiety Disorder and Depression Comorbidity: Results From a Clinical Trial
2017
-
Pharmacological Interventions for Reduction or Prevention of Weight Gain in Schizophrenia: A Cochrane Meta-Analysis
2017
-
Prediction of Functional Impairment Among Patients With Bipolar Disorder - A Machine Learning Approach
2017
-
Reward Learning Capacity in Binge Eating Disorder
2017
-
Adult ADHD With Anxiety Disorder and Depression Comorbidity in a Clinical Trial Cohort
2016
-
Common Genetic Variation in Oxytocin Receptors is Differentially Associated With Social Abilities Across Neurodevelopmental Disorders
2016
-
Relating Anticipatory Processing to Risky Decision- Making: Differences in Gambling Disorder and Healthy Controls
2016
-
Selective Dietary Supplementation in Early Postpartum is Associated With High Resilience Against Depressed Mood
2016
-
Common and Distinct White Matter Markers in Children with Attention-Deficit/Hyperactivity Disorder, Obsessive Compulsive Disorder and Autism Spectrum Disorder
2015
-
Effect of a Dietary Supplement on Predisposition to Depressed Mood in Postpartum
2015
-
Genetic Basis of Impulsive Behavior in Humans Project: Initial Delay Discounting
2015
-
Genome-Wide Association Analyses on Clinical Response to Duloxetine and Placebo in Major Depression Implicates a Gene Locus Involved in Nociception to be Associated with Placebo Response
2015
-
Hoarding Behaviours among Users of Online Classified Advertisements
2015
-
Reward Processing Across Addictive Disorders
2015
-
Damage-associated Molecular Patterns in Bipolar Disorder
2014
-
The Gut Microbiome in Patients with Anxiety, Depression and Inflammatory Bowel Disease
2014
-
The Use of Augmentation Strategies in Treatment Resistant Anxiety Disorders: A Systematic Review and Meta-Analysis
2014
-
A Trial Matching and Mismatching Ondansetron and Sertraline to 5-HTTLPR Alleles in Non-treatment Seeking Alcohol Dependent Individuals
2013
-
Baseline Neurocognitive Predictors of Responders to Treatment at 12 Month Follow-up for Major Depressive Disorder by Deep Brain Stimulation
2013
-
Changes in Cortical Thickness in Children of Parents with Bipolar Disorder
2013
-
Perceptions of Obsessive Compulsive Disorder and Potential Impact on Treatment Outcome
2013
-
Three-Dimensional Mapping of Hippocampal Anatomy in Unmedicated and Lithium-Treated Patients with Bipolar Disorder
2008
-
A cox-2 inhibitor (celecoxib) as a possible adjunctive agent to expedite treatment response in bipolar depression
2006
-
Effects of topiramate on alcohol cue reactivity and the subjective effects of drinking
2006
-
Three-dimensional mapping of hippocampal anatomy in unmedicated and lithium-treated patients with bipolar disorder
2006
-
Dose-dependent effects of topiramate on alcohol cue reactivity and the subjective effects of drinking: Preliminary data
2005
-
Paroxetine-induced increase in LDL cholesterol levels
2005
-
Tiagabine in patients with generalized anxiety disorder: A randomized, double-blind, placebo-controlled study
2004
-
SYSTEMIC LUPUS-ERYTHEMATOSUS AND RELATED NEUROIMMUNOLOGIC DISEASES - EFFECTS OF STEROIDS ON DISEASE EXPRESSION IN HUMAN AND IN ANIMAL-MODELS
1993
-
Addiction as a brain disease revised: why it still matters, and the need for consilience.
46:1715-1723.
2021
-
Response to “Addiction is a social disease: just as tenable as calling it a brain disease”.
46:1713-1714.
2021
-
Integration of brain and behavior measures for identification of data-driven groups cutting across children with ASD, ADHD, or OCD.
46:643-653.
2021
-
Clinical, behavioral, and neural measures of reward processing correlate with escitalopram response in depression: a Canadian Biomarker Integration Network in Depression (CAN-BIND-1) Report.
45:1390-1397.
2020
-
Single and repeated ketamine infusions for reduction of suicidal ideation in treatment-resistant depression.
45:606-612.
2020
-
Hippocampal tail volume as a predictive biomarker of antidepressant treatment outcomes in patients with major depressive disorder: a CAN-BIND report.
45:283-291.
2020
-
Urinary tetrahydrocannabinol is associated with poorer working memory performance and alterations in associated brain activity.
44:613-619.
2019
-
Neurofunctional Reward Processing Changes in Cocaine Dependence During Recovery.
41:2112-2121.
2016
-
Lower Monoamine Oxidase-A Total Distribution Volume in Impulsive and Violent Male Offenders with Antisocial Personality Disorder and High Psychopathic Traits: An [11C] Harmine Positron Emission Tomography Study.
40:2596-2603.
2015
-
The Dissociative Subtype of Posttraumatic Stress Disorder: Unique Resting-State Functional Connectivity of Basolateral and Centromedial Amygdala Complexes.
40:2317-2326.
2015
-
GABAB Receptor Agonist R-Baclofen Reverses Social Deficits and Reduces Repetitive Behavior in Two Mouse Models of Autism.
40:2228-2239.
2015
-
Prenatal Cocaine Exposure and Adolescent Neural Responses to Appetitive and Stressful Stimuli.
39:2824-2834.
2014
-
The Neuroeconomics of Alcohol Demand: An Initial Investigation of the Neural Correlates of Alcohol Cost–Benefit Decision Making in Heavy Drinking Men.
39:1988-1995.
2014
-
Influence of RGS2 on Sertraline Treatment for Social Anxiety Disorder.
39:1340-1346.
2014
-
Reduced Tissue Levels of Noradrenaline Are Associated with Behavioral Phenotypes of the TgCRND8 Mouse Model of Alzheimer's Disease.
37:1934-1944.
2012
-
Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients.
36:1219-1226.
2011
-
Neuronal Correlates of Brain-derived Neurotrophic Factor Val66Met Polymorphism and Morphometric Abnormalities in Bipolar Disorder.
34:1904-1913.
2009
-
Anterior Cingulate Volumes in Never-Treated Patients with Major Depressive Disorder.
33:3157-3163.
2008
-
Bilateral Hippocampal Volume Increase in Patients with Bipolar Disorder and Short-term Lithium Treatment.
33:361-367.
2008
-
Linking Animal Models of Psychosis to Computational Models of Dopamine Function.
32:54-66.
2007
-
Kappa-Opioid Agonist U69593 Potentiates Locomotor Sensitization to the D2/D3 Agonist Quinpirole: Pre- and Postsynaptic Mechanisms.
31:1967-1981.
2006
-
A Model of Antipsychotic Action in Conditioned Avoidance: A Computational Approach.
29:1040-1049.
2004
-
Chronic Lithium Treatment Inhibits Pilocarpine-Induced Mossy Fiber Sprouting in Rat Hippocampus.
28:1448-1453.
2003
has subject area
Identity
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)